This site is intended for healthcare professionals

This podcast series was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and speakers prior to broadcast. Editorial support for this podcast was provided by OmniaMed Communications. GPnotebook has had no input into the content of this podcast series. © 2022 Sanofi

Biosimilar insulin in practice (Promotional content from Sanofi)

MAT-XU-2202805 (v1.0) I October 2022
In this episode, Dr Amar Puttana, Dr Patrick Holmes and Dr Shafie Kamaruddin will discuss the evolving role of biosimilar insulin in the management of diabetes, how to assess biosimilar treatment options and incorporate their use into practice.


For GB Healthcare Professionals only

GB Prescribing information for Admelog (Insulin lispro 100 units/ml) can be accessed by clicking here.

GB Prescribing Information for Trurapi▼ (Insulin aspart 100 units/ml) can be accessed by clicking here.

Adverse events should be reported.

Great Britain reporting forms and information can be found at or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Sanofi Tel: 0800 090 2314. Alternatively, send via email to [email protected].

MAT-XU-2204698 (v1.0) I December 2022

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

This podcast episode is intended for healthcare professionals based in Great Britain


Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)